Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Glomerulonephritis”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Testing effectiveness (Phase 2)Ended earlyNCT05441826
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Minimal Change DiseaseFocal Segmental Glomerulosclerosis
Tenet Medicines 1
Testing effectiveness (Phase 2)Ended earlyNCT04905212
What this trial is testing

Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
RemeGen Co., Ltd. 15
Large-scale testing (Phase 3)Looking for participantsNCT07220083
What this trial is testing

Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Boehringer Ingelheim 286
Not applicableLooking for participantsNCT06242327
What this trial is testing

An Outcome Analysis of Primary Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 500
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Post-approval studies (Phase 4)Looking for participantsNCT04263922
What this trial is testing

Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

Who this might be right for
Renal Insufficiency, Chronic
The First Affiliated Hospital of Dalian Medical University 466
Not applicableStudy completedNCT00154661
What this trial is testing

Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis

Who this might be right for
Primary Glomerulonephritis
National Taiwan University Hospital 20
Large-scale testing (Phase 3)Study completedNCT04578834
What this trial is testing

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 518
Testing effectiveness (Phase 2)Ended earlyNCT04652570
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Tenet Medicines 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06830395
What this trial is testing

Study of CM313 in Subject With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Keymed Biosciences Co.Ltd 106
Not applicableLooking for participantsNCT06676007
What this trial is testing

A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)Early Initial Therapy
Sichuan Provincial People's Hospital 200
Not applicableLooking for participantsNCT07585981
What this trial is testing

Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.

Who this might be right for
IgA Glomerulonephritis
Chinese PLA General Hospital 30
Post-approval studies (Phase 4)UnknownNCT02063100
What this trial is testing

Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

Who this might be right for
GlomerulonephritisProteinuria
Chinese PLA General Hospital 720
Not applicableStudy completedNCT00521508
What this trial is testing

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Centre Hospitalier Universitaire de Saint Etienne 45
Testing effectiveness (Phase 2)Study completedNCT06670352
What this trial is testing

Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Who this might be right for
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd. 87
Large-scale testing (Phase 3)Looking for participantsNCT06994845
What this trial is testing

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Who this might be right for
Primary Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06635772
What this trial is testing

The Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

Who this might be right for
Immunoglobulin a Nephropathy
Hansoh BioMedical R&D Company 90
Not applicableLooking for participantsNCT04065438
What this trial is testing

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

Who this might be right for
Focal Segmental Glomerulosclerosis
Kaneka Medical America LLC 35
Load More Results